 <h1>Peramivir Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to peramivir: intravenous solution, solution iv (infusion)</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, peramivir may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking peramivir:</p><p>
<i>Less common</i>
</p><ul>
<li>Cloudy urine</li>
<li>fever</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Blistering, peeling, or loosening of the skin</li>
<li>chills</li>
<li>confusion as to time, place, or person</li>
<li>cough</li>
<li>diarrhea</li>
<li>difficulty swallowing</li>
<li>dizziness</li>
<li>fast heartbeat</li>
<li>hives, itching, skin rash</li>
<li>holding false beliefs that cannot be changed by fact</li>
<li>joint or muscle pain</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>red, irritated eyes</li>
<li>red skin lesions, often with a purple center</li>
<li>seeing, hearing, or feeling things that are not there</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots in the mouth or on the lips</li>
<li>tightness in the chest</li>
<li>unusual excitement, nervousness, or restlessness</li>
<li>unusual tiredness or weakness</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of peramivir may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>Less common</i>
</p><ul>
<li>Blurred vision</li>
<li>constipation</li>
<li>difficulty having a bowel movement</li>
<li>headache</li>
<li>nervousness</li>
<li>pounding in the ears</li>
<li>redness of the eardrum</li>
<li>slow or fast heartbeat</li>
<li>trouble sleeping</li>
<li>vomiting</li>
</ul><p>
<!-- end intravenous solution, solution iv (infusion) --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to peramivir: intravenous solution</i></p><h3>Hematologic</h3><p>Decreased neutrophil count (less than 1 x 10[9]/L) was reported in 8% of patients.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Decreased neutrophil count<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea, constipation, nausea, vomiting</p>
<p><b>Uncommon</b> (0.1% to 1%): Upper abdominal pain, abdominal discomfort, gastritis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Elevated serum glucose</p>
<p><b>Uncommon</b> (0.1% to 1%): Decreased appetite, decreased blood glucose, increased blood uric acid<sup>[Ref]</sup></p><p>Elevated serum glucose (greater than 160 mg/dL) was reported in 5% of patients.<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Elevated creatine phosphokinase</p>
<p><b>Uncommon</b> (0.1% to 1%): Arthralgia<sup>[Ref]</sup></p><p>Elevated creatine phosphokinase (at least 6 times the upper limit of normal [6 x ULN]) was reported in 4% of patients.<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Increased ALT, increased AST</p>
<p><b>Uncommon</b> (0.1% to 1%): Increased GGT</p>
<p><b>Postmarketing reports</b>: Liver disorder<sup>[Ref]</sup></p><p>Increased ALT (greater than 2.5 x ULN) was reported in 3% of patients.<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>Delirium, hallucinations, and abnormal behavior have been reported in influenza patients using this drug.  These side effects were primarily reported in pediatric patients, often with abrupt onset and rapid resolution; the contribution of this drug to such events has not been established.</p>
<p></p>
<p>Psychomotor hyperactivity was common in pediatric patients; this side effect was not reported in adults.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Insomnia</p>
<p><b>Frequency not reported</b>: Psychomotor hyperactivity</p>
<p><b>Postmarketing reports</b>: Delirium, abnormal behavior, hallucinations<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypertension</p>
<p><b>Uncommon</b> (0.1% to 1%): ECG QT prolonged<sup>[Ref]</sup></p><h3>Other</h3><p>Fever and tympanic membrane erythema were reported in 2% (each) of pediatric patients; these side effects were not reported in adults.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Increased blood lactate dehydrogenase</p>
<p><b>Uncommon</b> (0.1% to 1%): Decreased blood albumin, increased blood chloride, decreased blood lactate dehydrogenase, increased blood potassium, increased blood sodium, increased total protein, chest discomfort, fatigue</p>
<p><b>Frequency not reported</b>: Fever/pyrexia, tympanic membrane erythema/hyperemia<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Anaphylactic/anaphylactoid reactions, anaphylactic shock<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Pruritus was common in pediatric patients; this side effect was not reported in adults.<sup>[Ref]</sup></p><p><b>Uncommon</b> (0.1% to 1%): Dermatitis, drug eruption, eczema, urticaria</p>
<p><b>Rare</b> (less than 0.1%): Erythema multiforme</p>
<p><b>Frequency not reported</b>: Serious skin reactions, toxic epidermal necrolysis, pruritus</p>
<p><b>Postmarketing reports</b>: Stevens-Johnson syndrome, exfoliative dermatitis, rash<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Blood present in urine, urobilin present in urine, increased urine ketone body</p>
<p><b>Frequency not reported</b>: Proteinuria<sup>[Ref]</sup></p><p>Proteinuria (by dipstick analysis) was reported in 3% of pediatric patients; this side effect was not reported in adults.<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Uncommon</b> (0.1% to 1%): Increased blood urea, increased blood creatinine</p>
<p><b>Frequency not reported</b>: Acute renal failure, renal failure, prerenal failure, renal disorder, anuria, nephritis</p>
<p><b>Postmarketing reports</b>: Acute kidney injury, renal impairment</p><h3>Nervous system</h3><p><b>Uncommon</b> (0.1% to 1%): Hypoesthesia, paresthesia</p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Blurred vision</p><h3>Local</h3><p><b>Frequency not reported</b>: Injection site rash</p><p>Injection site rash was common in pediatric patients; this side effect was not reported in adults.</p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Rapivab (peramivir)." BioCryst Pharmaceuticals Inc, Durham, NC. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about peramivir</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>Drug class: neuraminidase inhibitors</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Peramivir Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Rapivab</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Influenza</li>
<li>Swine Flu</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to peramivir: intravenous solution</i></p><h3>Hematologic</h3><p>Decreased neutrophil count (less than 1 x 10[9]/L) was reported in 8% of patients.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Decreased neutrophil count<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea, constipation, nausea, vomiting</p><p><b>Uncommon</b> (0.1% to 1%): Upper abdominal pain, abdominal discomfort, gastritis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Common</b> (1% to 10%): Elevated serum glucose</p><p><b>Uncommon</b> (0.1% to 1%): Decreased appetite, decreased blood glucose, increased blood uric acid<sup>[Ref]</sup></p><p>Elevated serum glucose (greater than 160 mg/dL) was reported in 5% of patients.<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Elevated creatine phosphokinase</p><p><b>Uncommon</b> (0.1% to 1%): Arthralgia<sup>[Ref]</sup></p><p>Elevated creatine phosphokinase (at least 6 times the upper limit of normal [6 x ULN]) was reported in 4% of patients.<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): Increased ALT, increased AST</p><p><b>Uncommon</b> (0.1% to 1%): Increased GGT</p><p><b>Postmarketing reports</b>: Liver disorder<sup>[Ref]</sup></p><p>Increased ALT (greater than 2.5 x ULN) was reported in 3% of patients.<sup>[Ref]</sup></p><h3>Psychiatric</h3><p>Delirium, hallucinations, and abnormal behavior have been reported in influenza patients using this drug.  These side effects were primarily reported in pediatric patients, often with abrupt onset and rapid resolution; the contribution of this drug to such events has not been established.</p><p></p><p>Psychomotor hyperactivity was common in pediatric patients; this side effect was not reported in adults.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Insomnia</p><p><b>Frequency not reported</b>: Psychomotor hyperactivity</p><p><b>Postmarketing reports</b>: Delirium, abnormal behavior, hallucinations<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypertension</p><p><b>Uncommon</b> (0.1% to 1%): ECG QT prolonged<sup>[Ref]</sup></p><h3>Other</h3><p>Fever and tympanic membrane erythema were reported in 2% (each) of pediatric patients; these side effects were not reported in adults.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Increased blood lactate dehydrogenase</p><p><b>Uncommon</b> (0.1% to 1%): Decreased blood albumin, increased blood chloride, decreased blood lactate dehydrogenase, increased blood potassium, increased blood sodium, increased total protein, chest discomfort, fatigue</p><p><b>Frequency not reported</b>: Fever/pyrexia, tympanic membrane erythema/hyperemia<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Anaphylactic/anaphylactoid reactions, anaphylactic shock<sup>[Ref]</sup></p><h3>Dermatologic</h3><p>Pruritus was common in pediatric patients; this side effect was not reported in adults.<sup>[Ref]</sup></p><p><b>Uncommon</b> (0.1% to 1%): Dermatitis, drug eruption, eczema, urticaria</p><p><b>Rare</b> (less than 0.1%): Erythema multiforme</p><p><b>Frequency not reported</b>: Serious skin reactions, toxic epidermal necrolysis, pruritus</p><p><b>Postmarketing reports</b>: Stevens-Johnson syndrome, exfoliative dermatitis, rash<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Blood present in urine, urobilin present in urine, increased urine ketone body</p><p><b>Frequency not reported</b>: Proteinuria<sup>[Ref]</sup></p><p>Proteinuria (by dipstick analysis) was reported in 3% of pediatric patients; this side effect was not reported in adults.<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Uncommon</b> (0.1% to 1%): Increased blood urea, increased blood creatinine</p><p><b>Frequency not reported</b>: Acute renal failure, renal failure, prerenal failure, renal disorder, anuria, nephritis</p><p><b>Postmarketing reports</b>: Acute kidney injury, renal impairment</p><h3>Nervous system</h3><p><b>Uncommon</b> (0.1% to 1%): Hypoesthesia, paresthesia</p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Blurred vision</p><h3>Local</h3><p><b>Frequency not reported</b>: Injection site rash</p><p>Injection site rash was common in pediatric patients; this side effect was not reported in adults.</p><p id="ref_1">1. "Product Information. Rapivab (peramivir)." BioCryst Pharmaceuticals Inc, Durham, NC. </p><h2>More about peramivir</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>Drug class: neuraminidase inhibitors</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Peramivir Intravenous &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Influenza</li>
<li>Swine Flu</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>